Top Posters
Since Sunday
5
o
5
4
m
4
b
4
x
4
a
4
l
4
t
4
S
4
m
3
s
3
SlideshowReport

Immunoconjugate drugs for targeted chemotherapy

Description
a) The desirable features for each component of the immunoconjugate: targeting antibody, linker, and cytotoxic drug.

b) Common sites of attachment of drugs to the antibody constant regions are shown as orange spheres. The tumor-specific antigen binding sites are shown in green and yellow.

c) A schematic of the immunoconjugate. The acid-labile hydrazone linker is highlighted in green, but linker is stable in circulation in blood (pH 7.4); but, is cleaved in the acidic environment of the endosome following endocytosis into the tumor cell.
Related Images
Add Comment
Explore
Post your homework questions and get free online help from our incredible volunteers
  1044 People Browsing
Your Opinion
Which industry do you think artificial intelligence (AI) will impact the most?
Votes: 308